Certuity’s TG Therapeutics TGTX Stock Holding History

Certuity’s Portfolio TGTX Stock Details TGTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,380	Closed	-$312K	–	394
2021 Q3	$312K	Buy	+9,380	New	+$290K	0.06%	269

Other funds holding TGTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Certuity's TGTX Position: Q4 2021 in Review

Certuity sold out of TG Therapeutics (TGTX) in Q4 2021, closing a stake of 9,380 shares — an estimated $312K sold.

Certuity first reported a position in TGTX in Q3 2021 and held it in 1 quarter. The position peaked at $312K in Q3 2021. 194 funds tracked by Wall St. Rank hold TGTX as of Q4 2021.

Certuity reported no remaining TG Therapeutics position as of Q4 2021 after selling out during the quarter.
Certuity sold 9,380 TG Therapeutics shares in Q4 2021, an estimated $312K.
Certuity first reported a position in TG Therapeutics in Q3 2021 and held it in 1 quarter.
Certuity's TG Therapeutics position peaked at $312K in Q3 2021.
194 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2021.

Based on Certuity's 13F filing for Q4 2021, filed 14 Feb 2022.